Biopharmaceutical/Biotech

Access thought leadership from YourEncore Experts on the Biopharmaceutical & Biotech industry.

  • Improving R&D Productivity with Activity Based Costing

    Improving R&D Productivity with Activity Based Costing

    Today’s prevailing wisdom is that R&D costs are on the rise while ROI on those investments are down. The Tufts Center for the Study of Drug Development puts the total costs of new drug...

    Read Article
  • YourEncore Pharm-ers Almanac 2015 [WHITE PAPER]

    YourEncore Pharm-ers Almanac 2015 [WHITE PAPER]

    View Content
  • ×

    Subscribe to YourEncore's Life Sciences blog for thought leadership straight to your inbox!

    First Name
    Last Name
    Thank you!
    Error - something went wrong!
  • How Blockchain is Revolutionizing the World and Changing Healthcare as We Know It (Ep. 20 of The Pharmcast)

    How Blockchain is Revolutionizing the World and Changing Healthcare as We Know It (Ep. 20 of The Pharmcast)

        In this episode of The Pharmcast, we join YourEncore Expert, Darryl Glover, to discuss one of the hottest technologies on the market today: blockchain. We've heard some people...

    Read Article
  • Ten Tips for Enterprise Technology Adoption in Pharma

    Ten Tips for Enterprise Technology Adoption in Pharma

    The RFP processes are robust, the ROI models are compelling, the software is best of breed, and the expectations are high. So, why do so many software deployment programs in Pharma fail...

    Read Article
  • [WEBINAR] Process Mapping: The First Step in Unlocking Supply Chain Value43:10

    [WEBINAR] Process Mapping: The First Step in Unlocking Supply Chain Value

    Watch Video
  • State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19 of The Pharmcast)

    State of the Industry: U.S. Regulatory Policy Improvements (Ep. 19 of The Pharmcast)

      In this episode of The Pharmcast, we share a recording from our May 5th webinar, State of the Industry: U.S. Regulatory Policy Overview. Parthenon-EY and YourEncore recently...

    Read Article
  • The Frontiers of Rare Disease Development: Advances in Regulatory Science with Dr. Tim Franson (Ep. 18 of The Pharmcast)

    The Frontiers of Rare Disease Development: Advances in Regulatory Science with Dr. Tim Franson (Ep. 18 of The Pharmcast)

      This week on The Pharmcast, we catch up with Dr. Tim Franson to discuss the leading edge of rare disease drug development. Dr. Franson has been actively helping Parent Project...

    Read Article
  • [WEBINAR] State of the Industry Webinar:  U.S. Regulatory Policy Improvements56:51

    [WEBINAR] State of the Industry Webinar: U.S. Regulatory Policy Improvements

    Watch Video
  • 7 Best Practices in Biologics Launch Communications (Ep. 16 of The Pharmcast)

    7 Best Practices in Biologics Launch Communications (Ep. 16 of The Pharmcast)

      On this episode of The Pharmcast, Heidi Youngkin shares seven best practices for successful biologic launch communication. When it costs over $2.5B dollars to develop a drug,...

    Read Article
  • The Future is Here: Using Big Data and Artificial Intelligence in Oncology (Ep. 15 of The Pharmcast)

    The Future is Here: Using Big Data and Artificial Intelligence in Oncology (Ep. 15 of The Pharmcast)

    On this week's episode of The Pharmcast, we talk with YourEncore Expert, Philippe Barzin, on the future of big data and artificial intelligence in oncology. Based off Philippe's...

    Read Article
  • Working with the FDA: Developing a Regulatory Strategy That Works (Ep. 14 of The Pharmcast)

    Working with the FDA: Developing a Regulatory Strategy That Works (Ep. 14 of The Pharmcast)

    On this week's episode of The Pharmcast, we explore the key elements of an effective regulatory strategy and how to drive value to patient and shareholders by working with the FDA. We...

    Read Article
  • Riding the Policy Roller Coaster in 2017: A Policy Update with Dr. Tim Franson (Ep. 13 of The Pharmcast)

    Riding the Policy Roller Coaster in 2017: A Policy Update with Dr. Tim Franson (Ep. 13 of The Pharmcast)

    We are at a time of great change and transition in the FDA. The sitting FDA chief stepped down, just when the 21st Century Cures Act passed into law; PDUFA 6 is up for renewal this...

    Read Article
  • NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 on The Pharmcast)

    NDA Mistakes to Avoid: An Interview with Dr. Joseph Lamendola (Ep. 12 on The Pharmcast)

    Read Article
  • Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)

    Patient Engagement: Putting Rare Disease Patients First (Ep. 10 on The Pharmcast)

    This week on The Pharmcast, we turn our attention to the topic of rare disease, and more specifically: how to engage and educate rare disease patients to advance development. It's...

    Read Article
  • FDA 483 Responses: Avoiding Common Pitfalls and Deficiencies (Ep. 8 on The Pharmcast)

    FDA 483 Responses: Avoiding Common Pitfalls and Deficiencies (Ep. 8 on The Pharmcast)

    This week on The Pharmcast, we explore best practices and common pitfalls in FDA 483 Responses.  In 2015, there were an average of 175 inspections and 10 warning letters issued per...

    Read Article
  • Bioethics in Biopharma: Lessons on Safety, Big Data and Bioethics from Dr. Don Therasse  (Ep. 7 on The Pharmcast)

    Bioethics in Biopharma: Lessons on Safety, Big Data and Bioethics from Dr. Don Therasse  (Ep. 7 on The Pharmcast)

    This week on The Pharmcast, we talk with Dr. Don Therasse, former VP of Global Patient Safety for Eli Lilly & Company, and current Strategic Advisor for YourEncore. With over 26...

    Read Article
  • From Big Pharma to Biotech C-Suite: Industry and Career Insights from Dr. June Almenoff (Ep. 6 on The Pharmcast)

    From Big Pharma to Biotech C-Suite: Industry and Career Insights from Dr. June Almenoff (Ep. 6 on The Pharmcast)

    This week on The Pharmcast, we talk with Dr. June Almenoff, former President, Chief Medical Officer and Board Member of a biotech, which was recently acquired in 2014 by Actavis for...

    Read Article
  • 9 Biotech Valuation Killers (Ep. 3 of The Pharmcast)

    9 Biotech Valuation Killers (Ep. 3 of The Pharmcast)

      This week in the Pharmcast, we discuss "9 Biotech Valuation Killers" with Dr. Brian Daniels, the former SVP of Global Development for Bristol-Myers Squibb and now Venture Partner...

    Read Article
  • [WEBINAR] Investor Briefing: 6 Pharma Trends to Watch 201645:20

    [WEBINAR] Investor Briefing: 6 Pharma Trends to Watch 2016

    Watch Video
  • Leading the Bristol-Myers Squibb Transformation (Part 2) (Ep. 2 of The Pharmcast)

    Leading the Bristol-Myers Squibb Transformation (Part 2) (Ep. 2 of The Pharmcast)

      A continuation of our maiden voyage of the Pharmcast, we talk with a trio of former Bristol-Myers Squibb executives, who developed and delivered BMS’ “String of Pearls” strategy,...

    Read Article
  • loading
    Loading More...